Slingshot members are tracking this event:
Incyte set to initiate Phase 3 study of epacadostat plus pembrolizumab in first-line advanced melanoma
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Jun 22, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3 Study, Epacadostat, Pembrolizumab, Advanced Melanoma, Echo-301